Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,487 | 1,515 | 1,537 | 1,542 | 1,517 |
| Income taxes - deferred | -6,844 | 547 | 189 | -154 | 1,678 |
| Accounts receivable | -2,076 | -3,297 | -2,458 | -405 | 332 |
| Other Working Capital | 18 | -6,598 | -2,789 | -5,893 | 2,797 |
| Other Operating Activity | 11,278 | 5,629 | 4,433 | 895 | -2,542 |
| Operating Cash Flow | $3,863 | $-2,204 | $912 | $-4,015 | $3,782 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -17 | -16 | -16 | -18 |
| Net Acquisitions | -524 | -521 | -165 | -149 | -178 |
| Purchase Sale Intangibles | -161 | 0 | -142 | 0 | -1,641 |
| Investing Cash Flow | $-695 | $-538 | $-323 | $-165 | $-1,837 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 26,859 | 3,112 | N/A | 2,072 | 47 |
| Debt Repayment | -24,576 | -53 | -34 | -61 | -56 |
| Other Financing Activity | -1,685 | -643 | 1,901 | -487 | -1,531 |
| Financing Cash Flow | $598 | $2,416 | $1,867 | $1,524 | $-1,540 |
| Exchange Rate Effect | 30 | -48 | -94 | -77 | 42 |
| Beginning Cash Position | 9,273 | 9,647 | 7,285 | 10,018 | 9,571 |
| End Cash Position | 13,069 | 9,273 | 9,647 | 7,285 | 10,018 |
| Net Cash Flow | $3,766 | $-326 | $2,456 | $-2,656 | $405 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,863 | -2,204 | 912 | -4,015 | 3,782 |
| Capital Expenditure | -171 | -17 | -158 | -16 | -1,659 |
| Free Cash Flow | 3,692 | -2,221 | 754 | -4,031 | 2,123 |